IGFBP-2 and IGF-II: Key Components of the Neural Stem Cell Niche? Implications for Glioblastoma Pathogenesis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104749 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Abigail J Harland und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Endocrinology Group, Bristol Medical School, Translational Health Sciences, University of Bristol, Southmead Hospital, Bristol BS10 5NB, UK. Hauptthemen laut MEDLINE: Glioblastoma, Insulin-Like Growth Factor Binding Protein 2, Stem Cell Niche, Neural Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 267 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Southmead Hospital Charity, Southmead Hospital Charity, North Bristol Trust Registered Charity.
Abstract (Originalsprache)
Glioblastoma is a fatal and aggressive cancer with no cure. It is becoming increasingly clear that glioblastoma initiation is a result of adult neural stem cell (NSC) transformation—most likely those within the subventricular zone (SVZ). Indeed, transcriptomic analysis indicates that glioblastomas are reminiscent of a neurodevelopmental hierarchy, in which neural stem and progenitor markers are widely expressed by tumour stem-like cells. However, NSC fates and the cues that drive them are poorly understood. Studying the crosstalk within NSC niches may better inform our understanding of glioblastoma initiation and development. Insulin-like growth factor binding protein 2 (IGFBP-2) has a well-established prognostic role in glioblastoma, and cell-based mechanistic studies show the independent activation of downstream oncogenic pathways. However, IGFBP-2 is more commonly recognised as a modulator of insulin-like growth factors (IGFs) for receptor tyrosine kinase signal propagation or attenuation. In the adult human brain, both IGFBP-2 and IGF-II expression are retained in the choroid plexus (ChP) and secreted into the cerebral spinal fluid (CSF). Moreover, secretion by closely associated cells and NSCs themselves position IGFBP-2 and IGF-II as interesting factors within the NSC niche. In this review, we will highlight the experimental findings that show IGFBP-2 and IGF-II influence NSC behaviour. Moreover, we will link this to glioblastoma biology and demonstrate the requirement for further analysis of these factors in glioma stem cells (GSCs).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Endocrinology Group, Bristol Medical School, Translational Health Sciences, University of Bristol, Southmead Hospital, Bristol BS10 5NB, UK.
ORCID-Profile: Abigail J Harland, Claire M Perks
Förderung
- Southmead Hospital Charity
- Southmead Hospital Charity, North Bristol Trust Registered Charity
Zitieren
APA
Harland, A. J., & Perks, C. M. (2025). IGFBP-2 and IGF-II: Key Components of the Neural Stem Cell Niche? Implications for Glioblastoma Pathogenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104749
Vancouver
Harland AJ, Perks CM. IGFBP-2 and IGF-II: Key Components of the Neural Stem Cell Niche? Implications for Glioblastoma Pathogenesis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104749
BibTeX
@article{Harland2025,
author = {Harland, Abigail J and Perks, Claire M},
title = {IGFBP-2 and IGF-II: Key Components of the Neural Stem Cell Niche? Implications for Glioblastoma Pathogenesis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104749}
}
EUVIMED